Explore more publications!

Health Wire Cabo Verde: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Cabo Verde.

Press releases published on March 13, 2026

Inside the Newsroom: EIN Presswire Launches Series on What Journalists Really Look for in Press Releases
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
Propylene Oxide Market worth $18.88 billion by 2030, at a CAGR of 4.9%, says MarketsandMarkets™
SPRINT® PNS System Now Covered Nationally by Aetna®
Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
Connected Innovation and Specialty-Specific AI Take Center Stage at Nextech EDGE 2026
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Blue Cross and Blue Shield of Minnesota Advances Collaborative Efforts to Improve Outcomes and Close Gaps in Care
NDSS Partners with CoorDown to Present the International Awareness Campaign “JUST EVOLVE”
Sienna Announces March Dividend
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence
Equillium Announces $35 Million Financing with RA Capital Management
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
23andMe Introduces Reconstructed Ancestors a First-of-Its-Kind DNA Discovery Tool
SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results
Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments
TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions